Signal Peptide Database - Drosophila melanogaster

 Entry Details
ID   5318
Source Database   UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number   P25726    (Created: 1992-05-01 Updated: 2009-01-20)
UniProtKB/Swiss-Prot Entry Name   EST5B_DROPS
Protein Name   Esterase-5B
Gene   Est-5B
Organism Scientific   Drosophila pseudoobscura pseudoobscura
Organism Common   Fruit fly
Lineage   Eukaryota
  Metazoa
    Arthropoda
      Hexapoda
        Insecta
          Pterygota
            Neoptera
              Endopterygota
                Diptera
                  Brachycera
                    Muscomorpha
                      Ephydroidea
                        Drosophilidae
                          Drosophila
                            Sophophora
Protein Length [aa]   545
Protein Mass [Da]   60652
Features  
TypeDescriptionStatusStartEnd
signal peptide      potential   1   19
chain   Esterase-5B      20   545
disulfide bond      by similarity   84   103
disulfide bond      by similarity   259   271
disulfide bond      potential   515   536
glycosylation site   N-linked (GlcNAc...)   potential   113   113
glycosylation site   N-linked (GlcNAc...)   potential   421   421
glycosylation site   N-linked (GlcNAc...)   potential   507   507
sequence variant   (in strain: JR-106)      0   0
sequence variant   (in strain: GB-336, JR-126, JR- 460)      0   0
sequence variant   (in strain: GB-329, JR-32)      0   0
sequence variant   (in strain: GB-329, GB-336, JR-32, JR-460)      0   0
sequence variant   (in strain: GB-329, GB-336, JR-32, JR-460)      0   0
sequence variant   (in strain: GB-115)      0   0
sequence variant   (in strain: GB-4)      0   0
sequence variant   (in strain: JR-341)      0   0
sequence variant   (in strain: GB-336)      0   0
sequence variant   (in strain: GB-336, JR-32, JR-50, JR-106, JR-382)      0   0
sequence variant   (in strain: GB-329)      0   0
sequence variant   (in strain: GB-8)      0   0
sequence variant   (in strain: GB-336, JR-32, JR-50, JR-106, JR-126)      0   0
sequence variant   (in strain: GB-139, GB-329, JR-142, JR-460)      0   0
sequence variant   (in strain: JR-341)      0   0
sequence variant   (in strain: JR-50)      0   0
sequence variant   (in strain: JR-38, JR-382)      0   0
sequence variant   (in strain: GB-4, GB-115, JR- 142)      0   0
sequence variant   (in strain: JR-126)      0   0
sequence variant   (in strain: JR-341)      0   0
sequence variant   (in strain: JR-142, JR-460)      0   0
sequence variant   (in strain: GB-8, JR-50)      0   0
sequence variant   (in strain: GB-115, GB-336, JR-38, JR-106, JR-198, JR-382)      0   0
sequence variant   (in strain: GB-336)      0   0
sequence variant   (in strain: GB-4, JR-126, JR- 460)      0   0
sequence variant   (in strain: JR-198, JR-460)      0   0
sequence variant   (in strain: JR-50)      0   0
sequence variant   (in strain: GB-115, JR-50, JR-106, JR-126, JR-142, JR-198, JR-341, JR- 382)      0   0
sequence variant   (in strain: JR-32)      0   0
sequence variant   (in strain: JR-126)      0   0
sequence variant   (in strain: GB-4, GB-139, JR- 38)      0   0
sequence variant   (in strain: JR-106)      0   0
sequence variant   (in strain: JR-126)      0   0
active site   Acyl-ester intermediate   by similarity   207   207
active site   Charge relay system   by similarity   467   467
SP Length   19
 ----+----1----+----2----+----3----+----4----+----5
Signal Peptide MYCAKLILLLGCFWISSSA
Sequence MYCAKLILLLGCFWISSSASDPADPLLVDLPNGKLRGRDNGNYYSYESLP
YAEPPVGDLRFEAPQPYKQQWTDTFDATQPPVL
CMQWDQFIQGDDKLAGN
EDC
LTVSVYKPKNSSRNSFPVVAQIHGGAFMFGGASQNGHENFMREGNLI
LVKISYRLGPLGFVSTGDADLSGNFGLKDQRLALLWIKQNIASFGGEPEN
ILVIGH
SAGGGSVHLQVLREDFSKLAKAAISFSGNALDPWVVQQGGRGRA
FELGRIVG
CGQASDSVTLKKCLKSKPASEIVSAVRNFLVFAYVPFTPFGP
VVESPDAPEAFISQHPVDIIKSGKFAQVPWAVTYTTEDGGYNAALLLEKQ
ASSGRELIVDLNDRWFDWAPYLLFYRDSMTTIKDMDDYSRKLRQEYLGDR
RFSVESYWDLQRLFTDVLFK
NSTEISLDLHRKHGKSPVYAFVYDNPANTG
IGQGLAKRTDINFGTV
HGDDYFLIFENIVREPQLRSDEEIISRNFLKMLN
DFVLSE
NGTLAFGTCVFQDNVGSSKLQLLSITRNGCENLELESFP
Original MYCAKLILLLGCFWISSSASDPADPLLVDLPNGKLRGRDNGNYYSYESLP
YAEPPVGDLRFEAPQPYKQQWTDTFDATQPPVLCMQWDQFIQGDDKLAGN
EDCLTVSVYKPKNSSRNSFPVVAQIHGGAFMFGGASQNGHENFMREGNLI
LVKISYRLGPLGFVSTGDADLSGNFGLKDQRLALLWIKQNIASFGGEPEN
ILVIGHSAGGGSVHLQVLREDFSKLAKAAISFSGNALDPWVVQQGGRGRA
FELGRIVGCGQASDSVTLKKCLKSKPASEIVSAVRNFLVFAYVPFTPFGP
VVESPDAPEAFISQHPVDIIKSGKFAQVPWAVTYTTEDGGYNAALLLEKQ
ASSGRELIVDLNDRWFDWAPYLLFYRDSMTTIKDMDDYSRKLRQEYLGDR
RFSVESYWDLQRLFTDVLFKNSTEISLDLHRKHGKSPVYAFVYDNPANTG
IGQGLAKRTDINFGTVHGDDYFLIFENIVREPQLRSDEEIISRNFLKMLN
DFVLSENGTLAFGTCVFQDNVGSSKLQLLSITRNGCENLELESFP
 ----+----1----+----2----+----3----+----4----+----5
Hydropathies  
 

© 2007-2017 Dr. Katja Kapp, Kassel & thpr.net e. K., Dresden, Germany, last update 2010-06-11